Bersanelli M.; Buti S.; Rizzo M.; Cortellini A.; Cattrini C.; Massari F.; Masini C.; Vitale M.G.; Fornarini G.; Caffo O.; Atzori F.; Gatti A.; Macrini S.; Mucciarini C.; Galli L.; Morelli F.; Stellato M.; Fanelli M.; Corti F.; Zucali P.A.; Toscani I.; Dalla Volta A.; Gernone A.; Baldessari C.; La Torre L.; Zara D.; Gennari A.; Bracarda S.; Procopio G.; Porta C., GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak, «THERAPEUTIC ADVANCES IN UROLOGY», 2021, 13, Article number: 17562872211054302 , pp. 1 - 6 [Scientific article]Open Access
Lopez-Beltran A.; Cimadamore A.; Blanca A.; Massari F.; Vau N.; Scarpelli M.; Cheng L.; Montironi R., Immune checkpoint inhibitors for the treatment of bladder cancer, «CANCERS», 2021, 13, Article number: 131 , pp. 1 - 16 [Scientific article]Open Access
Massari F.; Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ardizzoni A.; Santoni M., Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials, «EUROPEAN JOURNAL OF CANCER», 2021, 154, pp. 120 - 127 [Scientific article]
Massari, Francesco; Rizzo, Alessandro; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Ardizzoni, Andrea; Santoni, Matteo, Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials, «EUROPEAN JOURNAL OF CANCER», 2021, 154, pp. 120 - 127 [Scientific article]
Ricci, Costantino; Franceschini, Tania; Giunchi, Francesca; Grillini, Marco; Ambrosi, Francesca; Massari, Francesco; Mollica, Veronica; Colecchia, Maurizio; Fiorentino, Michelangelo, Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis, «AMERICAN JOURNAL OF CLINICAL PATHOLOGY», 2021, 157, pp. 1 - 1 [Scientific article]
Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni A.; Massari F., Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials, «EUROPEAN UROLOGY FOCUS», 2021, 1077, pp. 1 - 8 [Scientific article]
Rizzo, Alessandro; Mollica, Veronica; Giunchi, Francesca; Dall'Olio, Filippo Gustavo; Rosellini, Matteo; Marchetti, Andrea; Franceschini, Tania; Schiavina, Riccardo; Brunocilla, Eugenio; Fiorentino, Michelangelo; Ardizzoni, Andrea; Massari, Francesco, Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 220, Article number: 153410 , pp. 1 - 5 [Scientific article]
Zong Y.; Montironi R.; Massari F.; Jiang Z.; Lopez-Beltran A.; Wheeler T.M.; Scarpelli M.; Santoni M.; Cimadamore A.; Cheng L., Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives, «EUROPEAN UROLOGY FOCUS», 2021, 7, pp. 955 - 963 [Scientific article]
Santoni M.; Massari F.; Montironi R.; Battelli N., Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages, «BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER», 2021, 1876, Article number: 188547 , pp. 188547 - 188551 [Scientific article]
Aurilio G.; Santoni M.; Massari F.; Cimadamore A.; Rizzo A.; Mollica V.; Verri E.; Battelli N.; Montironi R., Metabolomic profiling in renal cell carcinoma patients: News and views, «CANCERS», 2021, 13, Article number: 5229 , pp. 1 - 11 [Scientific article]Open Access
Rizzo A.; Santoni M.; Mollica V.; Fiorentino M.; Brandi G.; Massari F., Microbiota and prostate cancer, «SEMINARS IN CANCER BIOLOGY», 2021, 1044, pp. 1 - 8 [Scientific article]
Montironi R.; Cheng L.; Cimadamore A.; Mazzucchelli R.; Scarpelli M.; Santoni M.; Massari F.; Lopez-Beltran A., Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups?, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1530 - 1540 [Scientific article]Open Access
Santoni M.; Cimadamore A.; Massari F.; Sorgentoni G.; Cheng L.; Lopez-Beltran A.; Battelli N.; Montironi R., Narrative review: Predicting future molecular and clinical profiles of prostate cancer in the United States, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1562 - 1568 [Scientific article]Open Access
Aurilio G.; Cimadamore A.; Lopez-Beltran A.; Scarpelli M.; Massari F.; Verri E.; Cheng L.; Santoni M.; Montironi R., Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1521 - 1529 [Scientific article]Open Access
de Velasco G.; Ruiz-Granados A.; Reig O.; Massari F.; Climent Duran M.A.; Verzoni E.; Graham J.; Llarena R.; De Tursi M.; Donskov F.; Iglesias C.; Pandha H.S.; Garcia del Muro X.; Procopio G.; Oudard S.; Castellano D.; Albiges L., Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib, «BJU INTERNATIONAL», 2021, 128, pp. 254 - 261 [Scientific article]
